Mattias Björnmalm

Mattias Björnmalm

Top Cited Scholar 2024
Auto-generated profile, based on publicly available information

Mattias Björnmalm

Bionics Institute , East Melbourne , Victoria 3002 , Australia

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2015 in Science
Verified
Journal Article
Closed access
PDF file
JRJoseph J. Richardson
Joseph J. Richardson
MBMattias Björnmalm
Mattias Björnmalm
FCFrank Caruso
Frank Caruso
Thin-film fabrication: The deposition of thin films from multiple materials is essential to a range of materials fabrication processes. Layer-by-layer processes involve the sequential deposition of two or more materials that physically bond together. Richardson et al. review some of the techniques and materials that are used to make thin films, including sequential dip coating, spraying, and electrochemical deposition. Despite the versatility of the methods and the range of materials that can be deposited, the techniques remain mostly confined to the lab because of challenges in industrial scaling. But because there is tremendous scope for fine-tuning the structure and properties of the multilayers, there is interest in broadening the use of these techniques. Science , this issue 10.1126/science.aaa2491

23 November 2016 in Chemical Reviews
Verified
Journal Article
Closed access
JRJoseph J. Richardson
Joseph J. Richardson
JCJiwei Cui
Jiwei Cui
MBMattias Björnmalm
Mattias Björnmalm
JBJulia A. Braunger
Julia A. Braunger
HEHirotaka Ejima
Hirotaka Ejima
FCFrank Caruso
Frank Caruso

6 September 2018 in Nature Nanotechnology
Verified
Journal Article
Open access
PDF file
MFMatthew Faria
Matthew Faria
MBMattias Björnmalm
Mattias Björnmalm
KTKristofer J. Thurecht
Kristofer J. Thurecht
SKStephen J. Kent
Stephen J. Kent
RPRobert G. Parton
Robert G. Parton
FCFrank Caruso
Frank Caruso
Studying the interactions between nanoengineered materials and biological systems plays a vital role in the development of biological applications of nanotechnology and the improvement of our fundamental understanding of the bio–nano interface. A significant barrier to progress in this multidisciplinary area is the variability of published literature with regards to characterizations performed and experimental details reported. Here, we suggest a ‘minimum information standard’ for experimental literature investigating bio–nano interactions. This standard consists of specific components to be reported, divided into three categories: material characterization, biological characterization and details of experimental protocols. Our intention is for these proposed standards to improve reproducibility, increase quantitative comparisons of bio–nano materials, and facilitate meta analyses and in silico modelling.

31 July 2018 in Advanced Materials
Verified
Journal Article
Open access
PDF file
DFDenzil Furtado
Denzil Furtado
MBMattias Björnmalm
Mattias Björnmalm
SAScott Ayton
Scott Ayton
Ashley I. BushAshley I. Bush
Ashley I. Bush
KKKristian Kempe
Kristian Kempe
FCFrank Caruso
Frank Caruso
Therapies directed toward the central nervous system remain difficult to translate into improved clinical outcomes. This is largely due to the blood–brain barrier (BBB), arguably the most tightly regulated interface in the human body, which routinely excludes most therapeutics. Advances in the engineering of nanomaterials and their application in biomedicine (i.e., nanomedicine) are enabling new strategies that have the potential to help improve our understanding and treatment of neurological diseases. Herein, the various mechanisms by which therapeutics can be delivered to the brain are examined and key challenges facing translation of this research from benchtop to bedside are highlighted. Following a contextual overview of the BBB anatomy and physiology in both healthy and diseased states, relevant therapeutic strategies for bypassing and crossing the BBB are discussed. The focus here is especially on nanomaterial‐based drug delivery systems and the potential of these to overcome the biological challenges imposed by the BBB. Finally, disease‐targeting strategies and clearance mechanisms are explored. The objective is to provide the diverse range of researchers active in the field (e.g., material scientists, chemists, engineers, neuroscientists, and clinicians) with an easily accessible guide to the key opportunities and challenges currently facing the nanomaterial‐mediated treatment of neurological diseases.

15 October 2018 in Nature Materials
Verified
Journal Article
Closed access
PDF file
Shuaijun PanShuaijun Pan
Shuaijun Pan
RGRui Guo
Rui Guo
MBMattias Björnmalm
Mattias Björnmalm
JRJoseph J. Richardson
Joseph J. Richardson
LLLing Li
Ling Li
FCFrank Caruso
Frank Caruso

19 September 2017 in ACS Nano
Verified
Journal Article
Closed access
MBMattias Björnmalm
Mattias Björnmalm
Kris ThurechtKris Thurecht
Kris Thurecht
MMMichael Michael
Michael Michael
Andrew ScottAndrew Scott
Andrew Scott
FCFrank Caruso
Frank Caruso